APRINOIA Therapeutics

0 followers


APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Mark S. Shearman

Collapse
Bradford A. Navia
Chief Medical Officer
Masaomi Miyamoto
EVP of R&D & Operations
Lili Zhang
SVP, Head of Preclinical Development
Chin-Yin Tai
VP of Neurology
Tzu-Chen Yen
General Manager
Andrew D. Campbell
Vice President, Global Head Of Program Management
Lana Gladstein
Group General Counsel And Interim Chief Operations Officer